PubMed:32074786 / 1450-1606 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PAS-Enju

    {"project":"LitCovid-PAS-Enju","denotations":[{"id":"EnjuParser_T224","span":{"begin":0,"end":11},"obj":"JJ"},{"id":"EnjuParser_T225","span":{"begin":12,"end":19},"obj":"NN"},{"id":"EnjuParser_T226","span":{"begin":20,"end":22},"obj":"VBZ"},{"id":"EnjuParser_T227","span":{"begin":23,"end":29},"obj":"RB"},{"id":"EnjuParser_T228","span":{"begin":30,"end":41},"obj":"VBN"},{"id":"EnjuParser_T229","span":{"begin":42,"end":45},"obj":"IN"},{"id":"EnjuParser_T230","span":{"begin":46,"end":62},"obj":"JJ"},{"id":"EnjuParser_T231","span":{"begin":63,"end":69},"obj":"NN"},{"id":"EnjuParser_T232","span":{"begin":70,"end":72},"obj":"IN"},{"id":"EnjuParser_T233","span":{"begin":73,"end":81},"obj":"VBN"},{"id":"EnjuParser_T234","span":{"begin":82,"end":88},"obj":"NNS"},{"id":"EnjuParser_T235","span":{"begin":89,"end":93},"obj":"WDT"},{"id":"EnjuParser_T236","span":{"begin":94,"end":98},"obj":"VBP"},{"id":"EnjuParser_T237","span":{"begin":99,"end":102},"obj":"DT"},{"id":"EnjuParser_T238","span":{"begin":103,"end":114},"obj":"NNS"},{"id":"EnjuParser_T239","span":{"begin":115,"end":117},"obj":"IN"},{"id":"EnjuParser_T240","span":{"begin":118,"end":122},"obj":"NN"},{"id":"EnjuParser_T241","span":{"begin":123,"end":132},"obj":"NN"},{"id":"EnjuParser_T242","span":{"begin":133,"end":134},"obj":"-LRB-"},{"id":"EnjuParser_T243","span":{"begin":134,"end":141},"obj":"JJ"},{"id":"EnjuParser_T244","span":{"begin":142,"end":148},"obj":"NN"},{"id":"EnjuParser_T245","span":{"begin":149,"end":150},"obj":"NN"},{"id":"EnjuParser_T246","span":{"begin":151,"end":156},"obj":"NN"}],"relations":[{"id":"EnjuParser_R238","pred":"arg1Of","subj":"EnjuParser_T225","obj":"EnjuParser_T224"},{"id":"EnjuParser_R239","pred":"arg1Of","subj":"EnjuParser_T225","obj":"EnjuParser_T226"},{"id":"EnjuParser_R240","pred":"arg2Of","subj":"EnjuParser_T228","obj":"EnjuParser_T226"},{"id":"EnjuParser_R241","pred":"arg1Of","subj":"EnjuParser_T228","obj":"EnjuParser_T227"},{"id":"EnjuParser_R242","pred":"arg2Of","subj":"EnjuParser_T225","obj":"EnjuParser_T228"},{"id":"EnjuParser_R243","pred":"arg1Of","subj":"EnjuParser_T228","obj":"EnjuParser_T229"},{"id":"EnjuParser_R244","pred":"arg2Of","subj":"EnjuParser_T231","obj":"EnjuParser_T229"},{"id":"EnjuParser_R245","pred":"arg1Of","subj":"EnjuParser_T231","obj":"EnjuParser_T230"},{"id":"EnjuParser_R246","pred":"arg1Of","subj":"EnjuParser_T228","obj":"EnjuParser_T232"},{"id":"EnjuParser_R247","pred":"arg2Of","subj":"EnjuParser_T234","obj":"EnjuParser_T232"},{"id":"EnjuParser_R248","pred":"arg2Of","subj":"EnjuParser_T234","obj":"EnjuParser_T233"},{"id":"EnjuParser_R249","pred":"arg1Of","subj":"EnjuParser_T234","obj":"EnjuParser_T235"},{"id":"EnjuParser_R250","pred":"arg1Of","subj":"EnjuParser_T234","obj":"EnjuParser_T236"},{"id":"EnjuParser_R251","pred":"arg2Of","subj":"EnjuParser_T238","obj":"EnjuParser_T236"},{"id":"EnjuParser_R252","pred":"arg1Of","subj":"EnjuParser_T238","obj":"EnjuParser_T237"},{"id":"EnjuParser_R253","pred":"arg1Of","subj":"EnjuParser_T238","obj":"EnjuParser_T239"},{"id":"EnjuParser_R254","pred":"arg2Of","subj":"EnjuParser_T241","obj":"EnjuParser_T239"},{"id":"EnjuParser_R255","pred":"arg1Of","subj":"EnjuParser_T241","obj":"EnjuParser_T240"},{"id":"EnjuParser_R256","pred":"arg1Of","subj":"EnjuParser_T238","obj":"EnjuParser_T242"},{"id":"EnjuParser_R259","pred":"arg1Of","subj":"EnjuParser_T246","obj":"EnjuParser_T243"},{"id":"EnjuParser_R260","pred":"arg1Of","subj":"EnjuParser_T246","obj":"EnjuParser_T244"},{"id":"EnjuParser_R261","pred":"arg1Of","subj":"EnjuParser_T246","obj":"EnjuParser_T245"}],"text":"Neoadjuvant therapy is highly recommended for gastrointestinal cancer at advanced stages that meet the indications of NCCN guideline (gastric cancer T stage"}

    LitCovid-ArguminSci

    {"project":"LitCovid-ArguminSci","denotations":[{"id":"T11","span":{"begin":0,"end":156},"obj":"DRI_Background"}],"text":"Neoadjuvant therapy is highly recommended for gastrointestinal cancer at advanced stages that meet the indications of NCCN guideline (gastric cancer T stage"}

    LitCovid-PubTatorCentral

    {"project":"LitCovid-PubTatorCentral","denotations":[{"id":"T14","span":{"begin":46,"end":69},"obj":"Disease:MESH:D005770"},{"id":"T15","span":{"begin":134,"end":150},"obj":"Disease:MESH:D013274"}],"text":"Neoadjuvant therapy is highly recommended for gastrointestinal cancer at advanced stages that meet the indications of NCCN guideline (gastric cancer T stage"}

    LitCovid-OGER-BB

    {"project":"LitCovid-OGER-BB","denotations":[{"id":"T8","span":{"begin":46,"end":62},"obj":"UBERON:0005409"},{"id":"T9","span":{"begin":134,"end":141},"obj":"UBERON:0005409"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"Neoadjuvant therapy is highly recommended for gastrointestinal cancer at advanced stages that meet the indications of NCCN guideline (gastric cancer T stage"}

    LitCovid-TimeML

    {"project":"LitCovid-TimeML","denotations":[{"id":"tok240","span":{"begin":0,"end":11},"obj":"NNP"},{"id":"tok241","span":{"begin":12,"end":19},"obj":"NN"},{"id":"tok242","span":{"begin":20,"end":22},"obj":"VBZ"},{"id":"tok243","span":{"begin":23,"end":29},"obj":"RB"},{"id":"tok244","span":{"begin":30,"end":41},"obj":"VBN"},{"id":"tok245","span":{"begin":42,"end":45},"obj":"IN"},{"id":"tok246","span":{"begin":46,"end":62},"obj":"NN"},{"id":"tok247","span":{"begin":63,"end":69},"obj":"NN"},{"id":"tok248","span":{"begin":70,"end":72},"obj":"IN"},{"id":"tok249","span":{"begin":73,"end":81},"obj":"VBD"},{"id":"tok250","span":{"begin":82,"end":88},"obj":"NNS"},{"id":"tok251","span":{"begin":89,"end":93},"obj":"WDT"},{"id":"tok252","span":{"begin":94,"end":98},"obj":"VBP"},{"id":"tok253","span":{"begin":99,"end":102},"obj":"DT"},{"id":"tok254","span":{"begin":103,"end":114},"obj":"NNS"},{"id":"tok255","span":{"begin":115,"end":117},"obj":"IN"},{"id":"tok256","span":{"begin":118,"end":122},"obj":"NNP"},{"id":"tok257","span":{"begin":123,"end":132},"obj":"NN"},{"id":"tok258","span":{"begin":133,"end":134},"obj":"("},{"id":"tok259","span":{"begin":134,"end":141},"obj":"JJ"},{"id":"tok260","span":{"begin":142,"end":148},"obj":"NN"},{"id":"tok261","span":{"begin":149,"end":150},"obj":"NN"},{"id":"tok262","span":{"begin":151,"end":156},"obj":"NN"},{"id":"lookup38","span":{"begin":20,"end":22},"obj":"country_code"},{"id":"lookup39","span":{"begin":70,"end":72},"obj":"country_code"},{"id":"event16","span":{"begin":30,"end":41},"obj":"I_ACTION"},{"id":"event22","span":{"begin":73,"end":81},"obj":"OCCURRENCE"},{"id":"event35","span":{"begin":94,"end":98},"obj":"OCCURRENCE"}],"text":"Neoadjuvant therapy is highly recommended for gastrointestinal cancer at advanced stages that meet the indications of NCCN guideline (gastric cancer T stage"}

    LitCovid-PD-MONDO-v1

    {"project":"LitCovid-PD-MONDO-v1","denotations":[{"id":"T16","span":{"begin":63,"end":69},"obj":"Disease"},{"id":"T17","span":{"begin":134,"end":148},"obj":"Disease"},{"id":"T18","span":{"begin":142,"end":148},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0001056"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"Neoadjuvant therapy is highly recommended for gastrointestinal cancer at advanced stages that meet the indications of NCCN guideline (gastric cancer T stage"}

    LitCovid-PD-HP-v1

    {"project":"LitCovid-PD-HP-v1","denotations":[{"id":"T8","span":{"begin":63,"end":69},"obj":"Phenotype"},{"id":"T9","span":{"begin":134,"end":148},"obj":"Phenotype"}],"attributes":[{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0012126"}],"text":"Neoadjuvant therapy is highly recommended for gastrointestinal cancer at advanced stages that meet the indications of NCCN guideline (gastric cancer T stage"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T16","span":{"begin":63,"end":69},"obj":"Disease"},{"id":"T17","span":{"begin":134,"end":148},"obj":"Disease"},{"id":"T18","span":{"begin":142,"end":148},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0001056"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"Neoadjuvant therapy is highly recommended for gastrointestinal cancer at advanced stages that meet the indications of NCCN guideline (gastric cancer T stage"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":118,"end":122},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_29308"}],"text":"Neoadjuvant therapy is highly recommended for gastrointestinal cancer at advanced stages that meet the indications of NCCN guideline (gastric cancer T stage"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T8","span":{"begin":63,"end":69},"obj":"Phenotype"},{"id":"T9","span":{"begin":134,"end":148},"obj":"Phenotype"}],"attributes":[{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0012126"}],"text":"Neoadjuvant therapy is highly recommended for gastrointestinal cancer at advanced stages that meet the indications of NCCN guideline (gastric cancer T stage"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"52","span":{"begin":46,"end":69},"obj":"Disease"},{"id":"53","span":{"begin":134,"end":148},"obj":"Disease"}],"attributes":[{"id":"A52","pred":"tao:has_database_id","subj":"52","obj":"MESH:D004067"},{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"MESH:D013274"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Neoadjuvant therapy is highly recommended for gastrointestinal cancer at advanced stages that meet the indications of NCCN guideline (gastric cancer T stage"}